<DOC>
	<DOCNO>NCT01547078</DOCNO>
	<brief_summary>A multi-center , phase 2 , randomize , control study effect lyophilize plasma patient liver disease .</brief_summary>
	<brief_title>Clinical Study Lyophilized Plasma Patients With Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>1 . Male female patient least 18 year age . 2 . Patients liver disease . 3 . Patients need plasma therapy surgical invasive procedure evidence bleeding . 4 . Patients elevate international normalized ratio due liver disease . 5 . Patients give write informed consent write informed consent obtain patient 's legal representative behalf . 6 . Patients able willing comply procedure lay study protocol . 1 . Patients clinically unstable . 2 . Patients receive mediation could interfere result laboratory test . 3 . Patients congenital acquire coagulopathies nonhepatic origin . 4 . Pregnant nursing woman . 5 . Active illicit drug use . 6 . Patients participate another clinical treatment study currently past 1 month prior study inclusion . 7 . Patients previously enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>